ArticleCardiovascular diabetology2022

Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study.

Marta Baviera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.